Asthma Clinical Trial
— OEDIPUSOfficial title:
Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Cluster Randomised Trial
| Verified date | May 2009 |
| Source | Barts & The London NHS Trust |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: National Health Service |
| Study type | Interventional |
People from ethnic minority groups suffer worse ill-health from asthma than those from
majority groups. No studies have reduced emergency care for people from minority groups. We
have developed an education programme to address barriers to improved care for south Asian
people with asthma. The study is set in Tower Hamlets and Newham - the UK's most deprived
and ethnically diverse boroughs. We will invite all the local GP practices to take part, and
using a computer programme, randomised them (like tossing a coin) into two groups - a group
receiving usual care and a group receiving our educational programme. This comprises:
- Education for specialist nurse and GPs and practice nurses, using our adaptation of an
American education course, designed to improve shared-decision making, goal-setting and
patient-clinician partnership.
- Lay-led 'expert-patient' education in small groups for patients, using an adaptation of
another American course.
- Improved follow-up in primary care through appointment-booking by the specialist
nurse.We will invite south Asians aged 3-65 years with asthma after A&E attendance or
hospital admission to take part. Those registered with practices receiving the
educational programme will see the trial specialist nurse in a nurse-run clinic, where
the nurse:
1. provides self-management advice and a treatment plan,
2. makes a follow-up appointment in primary care
3. makes an appointment for lay-led 'expert-patient' sessions.Patients registered
with 'usual care' practices receive usual care.
We will decide if our education programme works by comparing the number of emergency visits
to GPs and hospital between the two groups.
| Status | Completed |
| Enrollment | 375 |
| Est. completion date | April 2009 |
| Est. primary completion date | April 2008 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 3 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Recent hospital attendance (A&E, admitted) with uncontrolled asthma - or recent out of hours (GP service) walk in centre attendance with uncontrolled asthma - South Asian ancestry (Bangladeshi, Indian, Pakistani, Sri Lankan) - registered with a GP in Newham or Tower Hamlets Exclusion Criteria: - patients not of South Asian origin - aged under 3 years - not currently registered with a local GP - physician diagnosis of pure COPD - patients unable to give informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Barts and TheLondon, Queen Marys's School of Medicine and Dentistry | London |
| Lead Sponsor | Collaborator |
|---|---|
| Barts & The London NHS Trust | Asthma UK, Department of Health (Service Support), Noreen Clarke, Professor of Public Health, Michigan University, Social Action for Health |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Primary outcomes are time to first unscheduled contact with acute asthma, and proportion of participants with unscheduled care, assessed from patient records 12 months after recruitment. | 12 months following recruitment date | ||
| Secondary | Secondary outcomes are generic (EQ5D) and disease specific quality of life (AQ20 and North of England scales), prescribing and costs. | 12 months following recruitment date |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|